Cargando…

Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells

Immunotoxins (ITs) are hybrid proteins combining the binding specificity of antibodies with the cytocidal properties of toxins. They represent a promising approach to lymphoma therapy. The cytotoxicity of two immunotoxins obtained by chemical conjugation of the plant toxin saporin-S6 with the anti-C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polito, Letizia, Mercatelli, Daniele, Bortolotti, Massimo, Maiello, Stefania, Djemil, Alice, Battelli, Maria Giulia, Bolognesi, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488032/ https://www.ncbi.nlm.nih.gov/pubmed/28556822 http://dx.doi.org/10.3390/toxins9060182

Ejemplares similares

High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin
por: Bortolotti, Massimo, et al.
Publicado: (2016)

Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer Therapy
por: Polito, Letizia, et al.
Publicado: (2011)

Saporin-S6: A Useful Tool in Cancer Therapy
por: Polito, Letizia, et al.
Publicado: (2013)

Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview
por: Polito, Letizia, et al.
Publicado: (2016)

Bouganin, an Attractive Weapon for Immunotoxins
por: Bortolotti, Massimo, et al.
Publicado: (2018)

Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule.
por: Flavell, D. J., et al.
Publicado: (1997)

Recognition and killing of tumour cells expressing heat shock protein 65 kD with immunotoxins containing saporin.
por: Poccia, F., et al.
Publicado: (1992)

Toxin and Immunotoxin Based Therapeutic Approaches
por: Bortolotti, Massimo, et al.
Publicado: (2022)

New Insights on Saporin Resistance to Chemical Derivatization with Heterobifunctional Reagents
por: Bortolotti, Massimo, et al.
Publicado: (2023)

Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.
por: Flavell, D. J., et al.
Publicado: (1995)

Ribosome-Inactivating Proteins from Plants: A Historical Overview
por: Bolognesi, Andrea, et al.
Publicado: (2016)

Plants Producing Ribosome-Inactivating Proteins in Traditional Medicine
por: Polito, Letizia, et al.
Publicado: (2016)

Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin
por: Flavell, D J, et al.
Publicado: (2001)

Targeting of saporin to CD25-positive normal and neoplastic lymphocytes by an anti-saporin/anti-CD25 bispecific monoclonal antibody: in vitro evaluation.
por: Tazzari, P. L., et al.
Publicado: (1993)

Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives
por: Mercatelli, Daniele, et al.
Publicado: (2018)

The Role of Cholesterol on Triterpenoid Saponin-Induced Endolysosomal Escape of a Saporin-Based Immunotoxin
por: Smith, Wendy S., et al.
Publicado: (2020)

Effectiveness of HB2 (anti-CD7)--saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice.
por: Morland, B. J., et al.
Publicado: (1994)

5-FU resistant EMT-like pancreatic cancer cells are hypersensitive to photochemical internalization of the novel endoglin-targeting immunotoxin CD105-saporin
por: Lund, Kaja, et al.
Publicado: (2017)

Momordica charantia, a Nutraceutical Approach for Inflammatory Related Diseases
por: Bortolotti, Massimo, et al.
Publicado: (2019)

The Effect of Small Molecule Pharmacological Agents on the Triterpenoid Saponin Induced Endolysosomal Escape of Saporin and a Saporin-Based Immunotoxin in Target Human Lymphoma Cells
por: Wensley, Harrison J., et al.
Publicado: (2021)

Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering?
por: Zanello, Andrea, et al.
Publicado: (2022)

Xanthine oxidoreductase in cancer: more than a differentiation marker
por: Battelli, Maria Giulia, et al.
Publicado: (2015)

Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects
por: Battelli, Maria Giulia, et al.
Publicado: (2016)

Hyperuricaemia, Xanthine Oxidoreductase and Ribosome-Inactivating Proteins from Plants: The Contributions of Fiorenzo Stirpe to Frontline Research
por: Bolognesi, Andrea, et al.
Publicado: (2017)

Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase
por: Battelli, Maria Giulia, et al.
Publicado: (2018)

Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a  Detoxifying Enzyme
por: Battelli, Maria Giulia, et al.
Publicado: (2016)

Pro-Aging Effects of Xanthine Oxidoreductase Products
por: Battelli, Maria Giulia, et al.
Publicado: (2020)

Xanthine oxidoreductase: A leading actor in cardiovascular disease drama
por: Polito, Letizia, et al.
Publicado: (2021)

Xanthine oxidoreductase: One enzyme for multiple physiological tasks
por: Bortolotti, Massimo, et al.
Publicado: (2021)

B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease.
por: Vooijs, W. C., et al.
Publicado: (1997)

Protein Synthesis Inhibition Activity by Strawberry Tissue Protein Extracts during Plant Life Cycle and under Biotic and Abiotic Stresses
por: Polito, Letizia, et al.
Publicado: (2013)

Ricin: An Ancient Story for a Timeless Plant Toxin
por: Polito, Letizia, et al.
Publicado: (2019)

Kirkiin: A New Toxic Type 2 Ribosome-Inactivating Protein from the Caudex of Adenia kirkii
por: Bortolotti, Massimo, et al.
Publicado: (2021)

Antibody Conjugates for Sarcoma Therapy: How Far along Are We?
por: Polito, Letizia, et al.
Publicado: (2021)

Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling
por: Mercatelli, Daniele, et al.
Publicado: (2020)

Emergence of immunoglobulin variants following treatment of a B cell leukemia with an immunotoxin composed of antiidiotypic antibody and saporin
Publicado: (1987)

Thermo-stability and antitumor activity on colon cancer cell lines of monoclonal anti-CEA antibody-saporin immunotoxin.
por: Manosroi, J., et al.
Publicado: (1992)

Efficacy and toxicity of a CD22-targeted antibody-saporin conjugate in a xenograft model of non-Hodgkin’s lymphoma
por: Kato, Jason, et al.
Publicado: (2012)

Sequence, Structure, and Binding Site Analysis of Kirkiin in Comparison with Ricin and Other Type 2 RIPs
por: Maiello, Stefania, et al.
Publicado: (2021)

Efficacy and safety of anti-CD45–saporin as conditioning agent for RAG deficiency
por: Castiello, Maria Carmina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ib3oc7ai7q2hh5vdi6bmiqf1gg